The Community Outreach group at Cleveland Clinic’s Taussig Cancer Center sought input from people at local faith-based organizations to better understand and address the history of health disparities in the community.Read More
Better Communication May Improve MDS Outcomes
Healthcare providers and patients have disparate views of the course of MDS and the value and limitations of treatment. Improved communication and education may increase understanding of the diseases and improve outcomes.
Seven Breast Cancer Breakthroughs
Recent clinical trials have identified new and better ways to treat breast cancer. From exercise for anastrozole arthralgias to promising PARP inhibitors for triple-negative breast cancer, there are many advances.
New agents in Multiple Myeloma and Amyloidosis
Promising Cleveland Clinic studies are open to evaluate new agents and regimens for multiple myeloma and amyloidosis. Multidisciplinary support is offered for patients with complex issues.
Liver Radioembolization Doubles Survival Time
In the Y90 radioembolization procedure, interventional radiologists deliver radioactive (Y90) resin or glass-based particles to liver tumors by catheter and provide a continuing radiation dose.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
April Featured Clinical Trials
Learn about featured clinical trials currently enrolling or search our trials database.
Hyperthermia Improves Response Rates in Recurrent Cancers
Clinical studies show that the application of heat to tumors, particularly superficial ones, in combination with radiation produces a better response than radiation alone. The procedure helps address the limitations of repeat radiation for many patients by effectively increasing radiation dose without substantially increasing side effects.
Tiny Nanoparticles May Make Huge Impact in Cancer Medicine
Submicroscopic nanoparticles may help overcome the obstacles that hamper traditional anti-cancer drugs. Their size and other unique properties enable targeted drug delivery to hard-to-access tumors, as well as aiding tumor boundary visualization.
Telemedicine Program Broadens Access to Radiation Oncology in Africa
International effort allows experts to confer on complex cases
Research Shows HDL Has Cancer-Fighting Ability
Apolipoprotein A1, a major component of HDL, blocks metastatic malignant melanoma and lung cancer through multiple pathways. ApoA1 injections not only inhibit tumor growth and progression in mice, but spur tumor and metastases regression.
Genetic Advances Fuel New Hope in Fight Against Myeloid Leukemias
Cleveland Clinic researchers have identified genetic mutations in a subset of leukemia patients. The mutations potentially can be targeted with drugs, introducing the prospect of personalized treatments for these cancers.